Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/4172
Title: Pre- and Post-operative determinants of transplantation-free survival after Fontan. The Australia and New Zealand experience
Authors: Gentles, T. L.
Bullock, A.
Ayer, J.
Alphonso, N.
d'Udekem, Y.
Celermajer, D. S.
Poh, C. L.
Cordina, R. L.
Iyengar, A. J.
Zannino, D.
Grigg, L. E.
Wheaton, G. R.
Issue Date: 2021
Source: 35 , 2021
Journal: IJC Heart and Vasculature
Abstract: Background: This review identifies the predictors of late mortality and heart transplantation that remain relevant in the contemporary population of patients with a Fontan circulation, focusing on the potential impact of post-Fontan morbidities on the late outlook of these patients. Methods and Results: A total of 1561 patients who had survived the Fontan operation in Australia or New Zealand from 1975 to 2018 were included in this review. Over a median duration of 11.4 years, there was a total of 117 deaths (7%) and 32 heart transplantations (2%). Freedom from death and heart transplantation at 10, 20 and 35 years post Fontan surgery were 94% (95% CI 93–95%), 87% (95 %CI 85–90%) and 66% (95 %CI 57–78%) respectively. Being male, having an atriopulmonary Fontan, pre-Fontan atrioventricular valve intervention, or prolonged pleural effusions post Fontan were predictive of late death or heart transplantation. However, time-dependent variables such as the development of atrial arrhythmia, protein/losing enteropathy or late ventricular dysfunction were stronger predictors of the same outcome. Patients who developed a time-dependent risk factor had a freedom from death and heart transplantation rate of 54% (95 %CI 43–66) at 15 years and 44% (95 %CI 33–57) at 25 years post Fontan. However, 95% (95 %CI 91–99) of patients without any of the identified risk factors were free from death or heart transplantation rate at 25 years post Fontan. Conclusion: In conclusion, the occurrence of post-operative complications such as PLE, arrhythmia and ventricular dysfunction will likely precede the late demise of these patients.L20134565252021-07-14
2021-09-22
DOI: 10.1016/j.ijcha.2021.100825
Resources: https://www.embase.com/search/results?subaction=viewrecord&id=L2013456525&from=exporthttp://dx.doi.org/10.1016/j.ijcha.2021.100825 |
Keywords: major clinical study;male;pleura effusion;postoperative care;postoperative complication;preoperative care;protein losing gastroenteropathy;risk factor;shunt thrombosis;supraventricular tachycardia;surgical mortality;tachycardia;thoracotomy;transplant free survival;transesophageal echocardiography;warfarinadult;article;atrial fibrillation;atriopulmonary connection;Australia and New Zealand;cavopulmonary connection;clinical outcome;congenital heart disease;coronary artery bypass graft;cytogenetics;death;echocardiography;female;follow up;Fontan procedure;heart arrhythmia;heart atrioventricular valve;heart atrium flutter;heart failure;heart left ventricle failure;heart transplantation;heart ventricle function;human;length of stay
Type: Article
Appears in Sites:Children's Health Queensland Publications

Show full item record

Page view(s)

56
checked on Feb 14, 2025

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.